Finance

Lists
Q3 2026 earnings • released • EPS beat +13.21% • Revenue beat +3.92%
See results
FRX:TSE
Fennec Pharmaceuticals Inc
CA$16.56
+3.18%
(+0.51) 1D
Nov 13, 4:00:00 PM GMT-5  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for FRX...
Open
CA$15.65
High
CA$16.94
Low
CA$15.65
Mkt. cap
562.04M
Avg. vol.
351.00
Volume
2.06K
52-wk high
CA$17.64
52-wk low
CA$7.59
EPS
-CA$0.17
Beta
1.12
Shares outstanding
35.31M
No. of employees
35
Open
CA$15.65
High
CA$16.94
Low
CA$15.65
Mkt. cap
562.04M
Avg. vol.
351.00
Volume
2.06K
52-wk high
CA$17.64
52-wk low
CA$7.59
EPS
-CA$0.17
Beta
1.12
Shares outstanding
35.31M
No. of employees
35
News stories
From web sources and news partners
About Fennec Pharmaceuticals Inc
CEO-
Employees35
Founded1996
HeadquartersDurham, North Carolina, United States
SectorHealth Care
IndustryBiotechnology
Websitefennecpharma.com
Last report
Nov 12, 2026
Fiscal period
Q3 2026
$0.12 / $0.11
+13.21%beat
Revenue / Est. (USD)
19.61M / 18.87M
+3.92%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
13.78M
15.11M
17.87M
19.61M
Cost of goods sold
1.76M
570.00K
721.00K
838.00K
Cost of revenue
1.76M
570.00K
721.00K
838.00K
Research and development expenses
20.00K
49.00K
118.00K
154.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
14.55M
14.61M
15.30M
13.96M
Operating expense
14.57M
14.66M
15.42M
14.12M
Total operating expenses
16.33M
15.23M
16.14M
14.95M
Operating income
-2.55M
-119.00K
1.74M
4.65M
Other non operating income
-
-
-
-
EBT including unusual items
-4.68M
201.00K
2.02M
4.97M
EBT excluding unusual items
-2.66M
201.00K
2.02M
4.97M
Income tax expense
106.00K
-
42.00K
332.00K
Effective tax rate
-2.26%
-
2.08%
6.68%
Other operating expenses
-
-
-
-
Net income
-4.79M
201.00K
1.97M
4.64M
Net profit margin
-34.75%
1.33%
11.04%
23.66%
Earnings per share
-0.10
-
-
0.12
Interest and investment income
228.00K
339.00K
287.00K
319.00K
Interest expense
-334.00K
-7.00K
-3.00K
-1.00K
Net interest expenses
-106.00K
332.00K
284.00K
318.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.53M
-93.00K
1.76M
4.68M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps